Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin, type I cuticular Ha3-II (KRT33B) is a member of the type I hair keratin gene family and encodes a structural protein that forms acidic intermediate filaments with type II keratins in hair and nails. The protein is expressed primarily in hair follicles and contributes to the structural integrity and resilience of hair shafts by forming heterodimers with type II keratins. Mutations or dysregulation of KRT33B may be associated with various hair and skin disorders. There are no known drugs directly targeting this protein, and it is not considered a therapeutic target but rather a structural component of epithelial cells
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin, type I cuticular Ha3-II (KRT33B).